SUBSCRIBE
SUBSCRIBE

Valeant Pharmaceuticals International

NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Deals
As Sarepta And Valeant Exit Hearings, Biotech Steps Into M&A
May 3, 2016
 · 
1 min read
Business
Valeant’s New CEO Will Make Over $500 Million if Stock Hits $270 By 2020
April 28, 2016
 · 
3 min read
Business
Critics Believe New Valeant CEO Joe Papa Jumped from One Troubled Drugmaker to Another
April 26, 2016
 · 
3 min read
Business
Perrigo Names New CEO as Joseph Papa Joins Rival Valeant
April 25, 2016
 · 
3 min read
Business
Valeant Close to Naming Perrigo’s Joseph Papa as New CEO
April 22, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Biogen, Regeneron and Valeant Rank High as Potential Takeover Targets for Allergan
April 21, 2016
 · 
3 min read
Former Valeant CEO Nabs $9+ Million Severance Deal and Consulting Role
Deals
Covered in $30 Billion Debt, Embattled Valeant Mulls Over Which Assets to Sell
April 19, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Embattled Valeant Working with Banks to Review Options Amid Interest from Buyout Firms
April 15, 2016
 · 
3 min read
Genetown
Cures Within Reach: “Creating The Opposite Of Valeant”
April 14, 2016
 · 
1 min read
Load More
IN THE PRESS
Bausch Health Announces Closing Of Incremental Amendment To Its Existing Credit Agreement And Redemption Of Its 7.500% Senior Notes Due 2021
November 27, 2018
 · 
3 min read
Policy
Perrigo Confirms Patent Challenge for Generic Version of Jublia® Topical Solution 10%
October 1, 2018
 · 
5 min read
Business
Ekso Bionics Appoints Jack Glenn as Chief Financial Officer
August 13, 2018
 · 
4 min read
Drug Development
Strategic appointment expands Atlantic Healthcare executive team
August 8, 2018
 · 
7 min read
Policy
Virtus Thwarts Efforts of Bausch Health (formerly known as Valeant) to Push Lower Priced Competing Drugs off the Market
August 1, 2018
 · 
1 min read
Business
Bausch Health Companies Inc. Completes Name Change
July 13, 2018
 · 
3 min read
FDA
Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%
July 9, 2018
 · 
3 min read
FDA
FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion
June 18, 2018
 · 
3 min read
Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye Drops
June 14, 2018
 · 
4 min read
Bausch + Lomb Introduces Ocuvite® Blue Light Eye Vitamins
June 12, 2018
 · 
4 min read
Load More